Research Article
CD49b, a Major Marker of Regulatory T-Cells Type 1, Predicts the Response to Antiviral Therapy of Recurrent Hepatitis C after Liver Transplantation
Table 3
Characteristics of responder and nonresponder groups at 18 months.
| Characteristics | Responder (PCR < 0)
| Nonresponder (PCR > 0)
| |
| % of patients | 62% | 38% | | Age (years) | | | 0.53 | Weight (kg) | | | 0.39 | HCV genotype | Gen 1: = 10 (62%) Gen 2: = 1 (6.5%) Gen 3: = 4 (25%) Gen 4: = 1 (6.5%) | Gen 1: = 8 (73%) Gen 2: = 0 Gen 3: = 1 (9%) Gen 4: = 2 (18%) | | Basal Creatinine (µmol/L) | | | 0.26 | Cyclosporin/Tacrolimus | 6 (46%)/7 (54%) | 3 (38%)/5 (62%) | | Use of EPO | All patients | All patients | | Viral load (log) | 6.22 ± 0.59 | 6.75 ± 0.42 | 0.54 | METAVIR score () | 1 (10) 2 (5) 3 (1) 4 (0) | 1 (5) 2 (3) 3 (2) 4 (1) | | Donnor age > 40 | 53% | 58% | NS |
|
|